JSPR
Companies
NASDAQ
Jasper Therapeutics Inc.
Health Care
$5.26
-$16.24 (-75.96%)
Price Chart
Overview
About JSPR
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Market Cap
$369.9M
Volume
837.6K
Avg. Volume
842.3K
P/E Ratio
-1.1172566
Dividend Yield
0.00%
Employees
42.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.63
Low Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, JSPR shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$369.9M
Volume837.6K
P/E Ratio-1.12
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025